Cargando…
Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology
Amplification and overexpression of MDM2 and CDK4 are well-known diagnostic criteria for well-differentiated liposarcoma (WDLPS)/dedifferentiated liposarcoma (DDLPS). Although it was reported that the depletion of MDM2 or CDK4 decreased proliferation in DDLPS cell lines, whether MDM2 and CDK4 induce...
Autores principales: | Kim, Yu Jin, Kim, Mingi, Park, Hyung Kyu, Yu, Dan Bi, Jung, Kyungsoo, Song, Kyoung, Choi, Yoon-La |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760642/ https://www.ncbi.nlm.nih.gov/pubmed/31160689 http://dx.doi.org/10.1038/s41374-019-0263-4 |
Ejemplares similares
-
Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
por: Laroche-Clary, Audrey, et al.
Publicado: (2017) -
Adipogenesis induces growth inhibition of dedifferentiated liposarcoma
por: Kim, Yu Jin, et al.
Publicado: (2019) -
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
por: Traweek, Raymond S., et al.
Publicado: (2022) -
Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report
por: Grifasi, Carlo, et al.
Publicado: (2013) -
Cracking the riddle of dedifferentiated liposarcoma: is EV-MDM2 a key?
por: Casadei, Lucia, et al.
Publicado: (2020)